Phytoestrogens for menopausal vasomotor symptoms

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Lethaby, Anne ^a   Marjoribanks, Jane ^a   Kronenberg, Fredi ^b   Roberts, Helen ^a   Eden, John ^c   Brown, Julie ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Department of Rehabilitation Medicine ^*  (United States)

^c ROYAL HOSPITAL FOR WOMEN   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; EQUOL; ERR 731; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GENISTEIN; HUMULUS LUPULUS EXTRACT; ISOFLAVONE DERIVATIVE; LINSEED EXTRACT; MF 11RCE; PHYTOESTROGEN; PLACEBO; RED CLOVER EXTRACT; SOYBEAN EXTRACT; UNCLASSIFIED DRUG;

ARTHRALGIA; BLOATING; BODY WEIGHT GAIN; CALORIC RESTRICTION; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DIETARY SUPPLEMENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOMETRIAL THICKNESS; EVENING DOSAGE; FRACTURE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GENITAL BLEEDING; HEADACHE; HORMONAL THERAPY; HOT FLUSH; HUMAN; LINSEED; LOW DRUG DOSE; MENOPAUSAL SYNDROME; MORNING DOSAGE; MYALGIA; NAUSEA; NIGHT SWEAT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SOYBEAN; SPOTTING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASOMOTOR DISORDER; CLOVER; DRUG EFFECT; FEMALE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SWEATING;

FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; PHYTOESTROGENS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS; SWEATING; TRIFOLIUM;

EID: 84897368187     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001395.pub4     Document Type: Review

References (204)

1. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology 1998;91:6-11.
2. Albertazzi P, Pansini F, Bottazzi M, Bonaccorsi G, de Aloysio D, Morton S. Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology 1999;94(2):229-31.
3. Pansini F, Albertazzi P, Bonaccorsi G, Zanotti C, Campobasso C, Negri C, et al.Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3-7 November 1996.
4. Aso T. Equol improves menopausal symptoms in Japanese women. Journal of Nutrition 2010;140:1386S-9S.
5. Aso T, Uchiyama S, Matsumura Y, Taguchi M, Nozaki M, Takamatsu K, et al.A natural S-Equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women's Health 2012;21(1):92-100.
6. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
7. Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM. A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation 2002;9:238-42.
8. Bicca ML de O, Horta BL, Lethaby AE. Double-blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms.
9. Brzezinski A, Adlercreutz H, Shaoul R, Rosler A, Shmueli A, Tanos V, Schenker JG. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4(2):89-94.
10. Burke GL, Legault C, Anthony M, Bland DR, Morgan TM, Naughton MJ, et al.Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003;10(2):147-53.
11. Campagnoli C, Abba C, Ambroggio S, Peris C, Perona M, Sanseverino P. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas 2005;51:127-34.
12. Carmigiani LO, Pedro AO, Cost-Paiva LH, Pinto-Neto AM. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas 2010;67:262-9.
13. Cheng G, Wilczek B, Warner M, Gustafsson J-A, Landgren B-L. Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14(3, Part 1):468-73.
14. Colli MC, Bracht A, Soares AA, de Oliveira AL, Boer CG, de Souza CGM, et al.Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food 2012;15(9):840-5.
15. Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, et al.Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo- controlled study. Menopause 2004;11:400-4.
16. D'Anna R, Cannata M, Atteritano M, Cancellieri F, Corrado F, Baviera G, et al.Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double-blind, placebo controlled study. Menopause 2007;14(4):648-55.
17. D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, et al.Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomised, double-blind, placebo-controlled study. Menopause 2009;16(2):301-6.
18. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, et al.Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998;1:124-9.
19. Del Giorno C, Maggio da Fonseca A, Bagnoli VR, Serrano de Assis J, Soares JM, Baracat EC. Effects of trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Revista da Associacao Medica Brasileira 2010;56(5):558-62.
20. Evans M, Ellito JG, Sharma P, Berman R, Guthrie N. The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomised, placebo-controlled study. Maturitas 2011;68:189-96.
21. Faure ED, Chantre P, Mares P. Effects of a standardised soy extract on hot flushes: a multicentre, double-blind, randomised placebo-controlled study. Menopause 2002;9(5):329-34.
22. Ferrari A. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research 2009;35(6):1083-90.
23. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al.Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause 2009;16(6):1156-66.
24. Han KK, Soares JM, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 2002;99:389-94.
25. Hanachi P, Golkho S. Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women. Journal of Biological Sciences 2008;8(4):789-93.
26. Heger M, Ventskovskiy BM, Borzenko I, Kneis KC, Rettenberger R, Kaszkin-Bettag M, et al.Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomised double-blind placebo-controlled trial. Menopause 2006;13(5):744-59.
27. Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006;54:164-75.
28. Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecological Endocrinology 2005;21(5):257-64.
29. Imhof M, Gocan A, Reithmayer F, Lipovac M, Schimitzek C, Chedraui P, et al.Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55:76-81.
30. Lipovac M, Chedraui P, Gruenhut C, Gocan A, Kurz C, Neuber B, et al.The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology 2012;28(3):203-7.
31. Jeri A. The use of an isoflavone supplement to relieve hot flushes. The Female Patient 2002;27:47-9.
32. Jou H-J, Wu S-C, Chang F-W, Ling P-Y, Chu KS, Wu W-H. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. International Journal of Gynecology and Obstetrics 2008;102:44-9.
33. Kaari C, Haidar MA, Soares Junior JM, Nunes MG, de Azevedo Quadros LG, Kemp C, et al.Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58.
34. Khaodhiar L, Ricciotti HA, Li L, Pan W, Schickel M, Zhou J, et al.Daidzein-rich isoflavone-aglycones are effective in reducing hot flashes in menopausal women. Menopause 2008;15(1):125-32.
35. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
36. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001;4:13-8.
37. Kotsopoulos D, Dalais FS, Liang Y-L, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000;3:161-7.
38. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge D, Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine 2011;171(15):1363-8.
39. Lewis JE, Nickell LA, Thompson LU, Szalai JP, Kiss A, Hilditch JR. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 2006;13(4):631-42.
40. Nahas E, Nahas-Neto J, Orsatti F, Carvalho E, Oliveira M, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double-blind, and placebo controlled study. Maturitas 2007;58:249-58.
41. Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility 2003;79(5):1112-7.
42. Penotti M, Fabio E, Rinaldi M, Omodei U, Bacchi M. Effects of soy-derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause, Berlin, Germany. 10-14 June 2002:Abstract F-27-01.
43. Radhakrishnan G, Agarwal N, Vaid N. Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition 2009;8(7):1009-17.
44. Sammartino A, Di Carlo C, Mandato VD, Bifulco G, De Stefano M, Nappi C. Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology 2003;17(1):45-9.
45. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2002;8(1):17-26.
46. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA 2003;290(2):207-14.
47. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double-blind randomized placebo-controlled study. Menopause 2000;7(4):236-42.
48. van de Weijer PHM, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-93.
49. Ye Y-B, Wang Z-L, Zhuo S-Y, Lu W, Liao H-F, Verbruggen MA, et al.Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomised placebo-controlled trial. Menopause 2012;19(7):791-8.
50. Albert A, Altabre C, Baro F, Cabero A, Cancelo MJ, Castelo-Branco C, et al.Assessment of the efficiency and safety of soya-extracted phytoestrogens (Glycine Max L), in the treatment of climacteric symptoms. Results of a mulicenter, open, prospective pilot study [Valoracion de la eficacia y seguridad de una preparacion de fitoestrogenos extraidos de la soja (Glycine Max L.) en al tratamiento de la sintomatologia climaterica. Resultados de un ensayo piloto multicentrico, abierto y prospectivo]. Toko-ginecologia Practica 2001;60(5):257-64.
51. Albertazzi P, Steel SA, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Climacteric 2005;8(4):371-9.
52. Aly M. Use of black cohosh (Cimicifuga racemosa) in postmenopausal women: a randomized controlled study. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S413-729.
53. Amato P, Young R, Cramer M, Lewis R, Murray M, Steinberg F, et al.The effect of soy isoflavone supplementation on menopausal quality of life: a multicenter, randomised controlled trial. 16th Annual Meeting of NAMS, San Diego, CA, USA. September-October 2005.
54. Amato P, Young RL, Steinberg FM, Murray MJ, Lewis RD, Cramer MA, et al.Effect of soy isoflavone supplementation on menopausal quality of life. Menopause 2013;20(4):443-7.
55. Atkinson C, Warren RML, Sala E, Dowsett M, Dunning AM, Healey CS, et al.Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Research 2004;6(3):R170-9.
56. Bai W, Henneicke-von Zepelin H-H, Wang S, Zheng S, Liu J, Zhang Z, et al.Efficacy and tolerability of a medicinal product containing isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58:31-41.
57. Baird DB, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, Weinberg CR, et al.Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1995;80(5):1685-90.
58. Cancellieri F, De Leo V, Genazzani AD, Nappi C, Parenti GL, Polatti F, et al.Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts. Maturitas 2007;56:249-56.
59. Carranza-Lira SC, Barahona OF, Ramos DP, Herrera J, Olivares-Segura A, Cardoso G, et al.Changes in symptoms, lipid and hormone levels after the administration of a cream with phytoestrogens in the climacteric: preliminary report. International Journal of Fertility 2001;46(6):296-9.
60. Caserta L, Caserta R, Torella M, Nappo C, de Lucia D, Panariello S. The effects of phytoestrogen therapy on the endometrium in postmenopausal women. Minerva Ginecologica 2005;57(5):551-5.
61. Chandeying V, Sangthawan M. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: Phase III study. Journal of the Medical Association of Thailand 2007;90(9):1720-6.
62. Chandeying V, Lamlertkittikul S. Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, Pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. Journal of the Medical Association of Thailand 2007;90(7):1274-80.
63. Chiechi LM, Putignano G, Guerra V, Schiavelli MP, Cisternino AM, Carriero C. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Maturitas 2003;45:241-6.
64. Cianci A, Cicero AFG, Colacurci N, Matarazzo MG, De Leo V. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecological Endocrinology 2012;28(9):699-702.
65. Cohn RD, Bornhauser C, MacManus D, Sadakane M, Read W. A study of lavender and tea tree oils on postmenopausal FSH levels and hot flash severity. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings 2009;27(15S):1516.
66. Colacurci N, Zarcone R, Borrelli A, De Franciscis P, Fortunato N, Cirillo M, et al.Effects of soy isoflavones on menopausal neurovegetative symptoms. Minerva Ginecologica 2004;56(5):407-12.
67. Dodin S, Lemay A, Jacques H, Legare F, Forest J-C, Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2004;90(3):1390-7.
68. Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacology, Biochemistry and Behaviour 2003;75:721-9.
69. Duncan AM, Underhill KEW, Xu X, LaValleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1999;84(10):3479-84.
70. Ehsanpour S, Salehi K, Zolfaghari B, Bakhtiari S. The effects of red clover on quality of life in postmenopausal women. Iranian Journal of Nursing and Midwifery 2012;17(1):34-40.
71. Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keeukeleire D, Heyerick A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine 2010;17(6):389-96.
72. Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M. A double-blind randomised study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8(5):338-46.
73. Harding C, Morton M, Gould V, McMichael Phillips D, Howell A, Bundred NJ. Dietary soy supplementation is oestrogenic in menopausal women (poster abstract). Second International Symposium on the role of soy in preventing and treating chronic disease, September 15-18 1996, Brussels, Belgium. 1996.
74. Hochanadel G, Shifren I, Zhdanova I, Maher T, Spiers P. Soy isoflavones (phytoestrogens) in the treatment of the cognitive and somatic symptoms of menopause. Fertility and Sterility 1999;71(4):22.
75. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: randomised, placebo-controlled trial of Japanese women. Menopause 2009;16(1):141-8.
76. Jenks BH, Iwashita S, Nakagawa Y, Ragland K, Lee J, Carson WH, et al.A pilot study on the effects of S-Equol compared to soy isoflavones on menopausal hot flash frequency. Journal of Women's Health 2012;21(6):674-82.
77. Jou HJ, Ling PY, Wu SC. Comparison of 70mg and 35mg isoflavone soya supplement for menopause symptoms. International Journal of Gynaecology and Obstetrics 2005;90(2):156-60.
78. Katz D, Evans M, Njike V, Hoxley M, Nawax H, Comerford B, et al.Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women. Climacteric 2007;10(6):500-7.
79. Kok L, Kreijkamp-Kaspers S, Grobbee DE, Lampe JW, van der Schouw YT. A randomized placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause 2005;12(1):56-62.
80. Kok L, Kreijkamp-Kaspers S, Grobbee DE, van der Schouw YT. Design and baseline characteristics of a trial on health effects of soy protein with isoflavones in postmenopausal women. Maturitas 2004;47:21-9.
81. Kolarov G, Nalbanski B, Kamenov Z. [Possibilities for an individualised approach to the treatment of climacteric symptoms with phytoestrogens] Bulgarian. Source not reported 2001;40:18-21.
82. Krzysztof D, Agnieszka S-M, Ewa P, Agnieszka K-S, Magdalena M, Agnieszka K. Efficacy of standardised isoflavones extract (Soyfem) (52-104 mg/24h) in moderate and medium-severe climacteric syndrome. Ginekologia Polska 2007;78:307-11.
83. Lamlertkittikul S, Chandeying V. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: phase II study. Journal of the Medical Association of Thailand 2004;87:33-40.
84. Manonai J, Songchitsomboon S, Chanda K, Hong JH, Komindr S. The effect of a soy-rich diet on urogenital atrophy: a randomized crossover trial. Maturitas 2006;54:135-40.
85. Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai HY, Theppisai U. Effects and safety of Puerarua mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy post-menopausal women. Menopause 2008;15(3):530-5.
86. Mittal N, Hota D, Dutta P, Bhansali A, Suri V, Aggarwal N, et al.Evaluation of effect of isoflavone on thyroid economy and autoimmunity in oophorectomised women: a randomised, double-blind, placebo controlled trial. Indian Journal of Medical Research 2011;133:633-40.
87. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-95.
88. Nahas EP, Neto JN, de Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004;48(4):372-80.
89. Nasrin B, Azam A, Sedigheh A, Ahmad E, Habibollah E. Effect of powder of flaxseed on hot flashes in women at the climacteric. Iranian Journal of Obstetrics, Gynecology and Infertility 2011;14(1):37-47.
90. Newton KM, Reed SD, La Croix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Principal results of the herbal alternatives for menopause (HALT) study. 16th Annual Meeting of the North American Menopause Society, San Diego, CA. 2005 September 28-October 5:S-13.
91. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy or placebo. Annals of Internal Medicine 2006;145:869-79.
92. Reed SD, Newton KM, Grothaus L, Ehrlich K, Grieco V, La Croix AZ. Vaginal findings from a randomized placebo-controlled trial of black cohosh, multibotannical herbs and dietary soy for hot flushes: the herbal alternatives (HALT) study. 7th European Congress on Menopause, Istanbul, Turkey. 2006 June 3-7:s102-3.
93. Reed SD, Newton KM, Grothaus L, Ehrlich K, Schenk J, La Croix AZ. The herbal alternative for menopause study (HALT: dietary soy intervention). 7th European Congress on Menopause, Istanbul, Turkey. 2006 June 3-7:s63.
94. Reed SD, Newton KM, La Croix AZ, Grothaus LA, Ehrlich K, Guiltinan K. The herbal alternatives for menopause (HALT) study: endometrial safety. 16th Annual Meeting of the North American Menopause Society, San Diego, CA. 2005 September 28-October 5:P-70.
95. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Vaginal, endometrial and reproductive hormone findings: randomised placebo-controlled trial of black cohosh, multibotannical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) study. Menopause 2008;15(1):51-8.
96. Nikander E, Rutanen E-M, Nieminen P, Wahlstrom T, Ylikorkala O, Tiitinen A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertility and Sterility 2005;83(1):137-42.
97. Palacios S, Pornel B, Vazquez F, Aubert L, Chantre P, Mares P. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric 2010;43(4):368-75.
98. Pedro AO, Carmigiani LO, Pinto-Nero AM, Costa-Paiva LS. The effect of a soy-based dietary supplement on the vaginal epithelium and endometrium in postmenopause: a randomised double blind controlled clinical trial. Menopause 2012;19(12):1402-3.
99. Pop E, Fischer L, Coan A, Gitzinger M, Nakamura J, Zeisel S. Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase 1 clinical trial. Menopause 2008;15(4):684-92.
100. Pruthi S, Qin R, Terstreip S, Liu H, Loprinzi C, Shah T, et al.A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause 2012;19(1):48-53.
101. Quaas AM, Kono N, Mack WJ, Hodis H, Paulson RJ, Shoupe D. The effect of isoflavone soy protein (ISP) supplementation on endometrial thickness, hyperplasia and endometrial cancer risk in postmenopausal women: a randomised controlled trial. Fertility and Sterility 2012;97(3 Suppl):S6 (abstract).
102. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, et al.Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment trial. Journal of Clinical Oncology 2000;18(5):1068-74.
103. Rotem CA, Kaplan B. Phyto-female complex for the relief of hot flushes, night sweats and quality of sleep: randomised controlled double-blind pilot study. Gynecological Endocrinology 2007;23(2):117-22.
104. Russo R, Corosu R. The clinical use of a preparation based on phytoestrogens in the treatment of menopausal disorders. Acta Bio-Medica de l Ateneo Parmense 2003;74(3):137-43.
105. Sammartino A, Tommaselli GA, Gargano V, Di Carlo C, Attianese W, Nappi C. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind randomized placebo-controlled trial. Gynecological Endocrinology 2006;22(11):646-50.
106. Scambia G, Mango D, Signorile PG, Angeli RA, Palena C, Gallo D, et al.Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7(2):105-11.
107. Scwen R, Griewe J, Desai P, Jackson R, Ausio Pharmaceuticals and Cincinnati College of Pharmacy. Development of S-equol, a natural selective estrogen receptor beta agonist for the treatment of menopausal symptoms. Menopause 2010;17(6):12-7.
108. Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, et al.Soy isoflavones and melatonin for the relief of climcteric symptoms: a multicenter, double blind, randomized study. Maturitas 2004;47:11-20.
109. Steinberg F, Murray M, Lewis R, Cramer M, Amato P, Young R, et al.Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. American Journal of Clinical Nutrition 2011;93(2):356-67.
110. Uesugi S, Watanabe S, Ishiwata N, Uehara M, Ouchi K. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. BioFactors 2004;22:221-8.
111. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized double-blind placebo-controlled study. Fertility and Sterility 2004;82(1):145-8.
112. van Patten CL, Olivotto IA, Chambers GK, et al.Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomised controlled clinical trial. Journal of Clinical Oncology 2002;20(6):1449-55.
113. Verhoeven MO, van der Mooren MJ, van de Weijer PHM, Verhegem PJE, van der Burgt LMJ, Kenemans P. Effect of a combination isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005;12(4):412-20.
114. Virojchaiwong P, Suvithayasiri V, Itharat A. Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms. Archives of Gynecology & Obstetrics 2011;284(2):411-9.
115. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6(1):7-13.
116. Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, et al.Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003;10(4):352-61.
117. Xue X, Niu J, Wang J, Ai H. A prospective controlled study on the clinical therapeutic effect of treatment of menstrual syndrome by isoflavone of soybean. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24(9):835-6.
118. Yang T-S, Wang S-Y, Yang Y-C, Su C-H, Lee F-K, Chen S-C, et al.Effects of standardised phytoestrogen on Taiwanese menopausal women. Taiwanese Journal of Obstetrics and Gynecology 2012;51(2):229-35.
119. Agrawal S, Shah D. Phytoestrogens and quality of life. Royal College of Obstetricians and Gynaecologists 6th International Meeting, Cairo, Egypt. 2005 September 27-30.
120. Baker MB, Ciccone M, Wilson M, Stanczyk F, Shoupe D. A double-blind placebo controlled trial on the effects of a licorice extract on menopausal symptoms. Fertility and Sterility 2011;96(3 Suppl):S5.
121. Garcia-Martin A, Quesada Charneco M, Alvarez Guisado A, Jimenez Moleon JJ, Fonolla Joya J, Munoz-Torres M. Effect of milk product with soy isoflavones on quality of life and bone metabolism. Medicina Clinica 2012;138(2):47-51.
122. Mucowski SJ, Shoupe D, Dang H, Henderson V, Kono N, Hodis N, et al.The effect of soy isoflavones on menopausal vasomotor flushing. Fertility and Sterility 2012;99(Suppl 1):S35 (abstract).
123. Nahidi F, Zare E, Mojab F, Alavi Majd H. Effects of licorice root extract on the number of nocturnal hot flashes in menopausal women. Journal of Nursing and Midwifery 2009;19(67).
124. Paixao JS, Fonseca AM, Bagnoli VR, Arie WMY, Penteado SRL, Junqueira PA, et al.Effects of genistein on endometrial thickness and climacteric symptoms: a double blind randomized controlled study. 16th Annual Meeting of North American Menopause Society, San Diego, CA, USA. 2005 September 28-October 5.
125. Sekhavat L, Firouzabadi RD. Effect of soya protein on symptoms of hot flash in menopausal women in Yazd, Iran. Iranian Journal of Obstetrics, Gynecology and Infertility 2012;15(6):10-5.
126. Stanosz S, Puk E, Grobelny W, Stanosz M, Kazikowska A. Evaluation of the efficacy and tolerance of Soyfem in women in the early menopausal period [Polish]. Przeglad Menopauzalny 2006;5(3):182-90.
127. Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T, et al.Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone blinding globulin (SHBG). Journal of Steroids and Biochemistry 1987;27:1135-44.
128. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical Laboratory Investigations 1990;50(Suppl):3-23.
129. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environmental Health Perspectectives 1995;103(Suppl 7):103-12.
130. AFSSA Working Group. Safety and benefit of phytoestrogens - recommendations. INSERM-CRLC M France 2005:1-8.
131. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al.Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003;290(13):1739-48.
132. Ayers B, Hunter MS. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013;16:235-9.
133. Bair YA, Gold EB, Azari RA, et al.Use of conventional and complementary health care during the transition to menopause: longitudinal results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005;12:31-9.
134. Bakken K, Eggen AE, Lund E. Side-effects of hormone replacement therapy and influence in pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstetrica Gynecologica Scandinavica 2004;83(9):850-6.
135. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Australian Vetinary Journal 1946;22:2-12.
136. Beral V. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362(9382):419-27.
137. Bestul MB, McCollum M, Hansen LB, Saseen JJ. Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy 2004;24(4):495-9.
138. Bjorn I, Backsrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32(2):77-86.
139. Bolanos R, Del Castillo A, Francia J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause 2010;17(3):660-6.
140. Bolego C, Poli A, Cignarella A, Paoletti R. Phytoestrogens: pharmacological and therapeutic perspectives. Current Drug Targets 2003;4:77-87.
141. Cassidy A, Bingham S, Carlson J, Setchell KDR. Biological effects of plant estrogens in premenopausal women. FASEB J 1993;A:866.
142. Chao MT, Wade C, Kronenberg F, Kalmuss D, Cushman LF. Women's reasons for complementary and alternative medicine use: racial/ethnic differences. Journal of Alternative and Complementary Medicine 2006;12(8):719-22.
143. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle aged women: a longitudinal study. Menopause 2009;16:453-7.
144. Committee on Toxicity. Phytoestrogens and health. London, 2003:1-444.
145. Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007;14:153-9.
146. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Archives of Women's Mental Health 2007;10(6):247-57.
147. European Medicines Agency. Evaluation of medicines for human use: guidelines for hormone replacement therapy. www.emea.eu.int (accessed on 20 January 2006).
148. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. Clinical Endocrinology and Metabolism 1995;80(8):2354-8.
149. Freedman RR. Physiology of hot flashes. American Journal of Human Biology 2001;13(4):453-64.
150. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214.
151. Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. Journal of Women's Health 2005;14(7):634-49.
152. Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Archives of Internal Medicine 2001;161:1161-72.
153. Gold EB, Colvin A, Avis N, Bromberger J, Greendate GA, Powell L, et al.Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. American Journal of Public Health 2006;96(7):1226-35.
154. Gold EB, Bair Y, Zhang G, Utts J, Greendate GA, Upchurch D, et al.Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause 2007;14(4):612-23.
155. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al.Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study. Annals of Internal Medicine 2000;132(9):689-96.
156. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Annals of Internal Medicine 2004;140(3):184-8.
157. Haimov-Kochman R, Hchner-Celnikier D. Hot flashes revisited: pharmacological and herbal options for hot flush management. What does the evidence tell us?. Acta Obstetrica Gynecologica Scandinavica 2005;84:972-9.
158. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertility and Sterility 2012;97(4):843-51.
159. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
160. Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006;55:203-11.
161. Hunter MS, Gentry-Maharaj A, Ryan A, Burnell M, Lanceley A, Fraser L, et al.Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54-65. BJOG 2012;119:40-50.
162. Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptoms - a systematic review. Maturitas 2004;47:1-9.
163. Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, Lampen A. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - a systematic review. Molecular Nutrition and Food Research 2009;53:1084-97.
164. Knight D, Eden JA. A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology 1996;87:897-904.
165. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstetrics and Gynecology 2004;104(4):824-36.
166. Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Canadian Journal of Physiology and Pharmacology 1987;65(6):1312-24.
167. Kronenberg F. Hot flashes: epidemiology and physiology. Annals of the New York Academy of Sciences 1990;592:52-86.
168. Kuiper G, Carlsson B, Grandien K, et al.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
169. Low Dog T. Menopause: a review of botanical dietary supplements. American Journal of Medicine 2005;118(12B):98-108.
170. MacLennan A. The four harms of harmless therapies (editorial). Climacteric 1999;2:73-4.
171. Mahady GB, Parrot J, Lee C, Yun GS, Dan A. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 2003;10:65-72.
172. Makela S, Davis VL, Tally WC. Dietary estrogens act through estrogen-receptor mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environmental Health Perspectives 1994;102:572-8.
173. Messina M, Hughes C. Efficacy of soy foods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. Journal of Medicinal Food 2003;6:1-11.
174. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus luputus L.) and beer. Journal of Clinical Endocrinology and Metabolism 1999;84:2249-52.
175. Muthyala RS, Ju YH, Sheng S. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic and Medicinal Chemistry Letters 2004;12:1559-67.
176. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. American Journal of Epidemiology 2001;153:790-3.
177. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11(1):11-33.
178. North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society. Menopause 2011;18(7):732-53.
179. North American Menopause Society. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19(3):257-71.
180. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms. Archives of Internal Medicine 2006;166:1453-65.
181. Newton KM, Buist DSM, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstetrics and Gynecology 2002;100:18-25.
182. Roussouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized trial. JAMA 288;3:321-33.
183. Roussouw JE, Prentice RL, Manson JE. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77.
184. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. British Journal of Nutrition 2003;(Suppl):45-8.
185. Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 2005;365:1657-61.
186. Seibel MM. Treating hot flushes without hormone replacement therapy. Journal of Family Practice 2003;52(4):291-6.
187. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal oestrogens of dietary origin: possible role in hormone dependent disease. American Journal of Clinical Nutrition 1984;2:49-56.
188. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phytoestrogens from soy-based infant formula. Lancet 1997;350:23-7.
189. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 1998;68(Suppl):1333-46.
190. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 2002;132:3577-84.
191. Sievert LL, Morrison L, Brown DE, Reza AM. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause 2007;14(2):261-9.
192. Sikon A, Thacker HL. Treatment options for menopausal hot flashes. Seminars in Reproductive Medicine 2004;71:578-82.
193. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology 2001;97:109-15.
194. Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomised controlled trials. Menopause 2012;19(7):776-90.
195. Tempfer CB, Froese G, Heinze G, Bentz EK, Hefler LA, Huber JC. Side effects of phytoestrogens: a meta-analysis of randomised trials. American Journal of Medicine 2009;122:939-46.
196. Thompson LU, Robb P, Serraino M. Mammalian lignan production from various foods. Nutrition and Cancer 1991;16:43-52.
197. Travers C, O'Neill SM, Khoo S-K, King R. Hormones down under. Hormone therapy use after the Women's Health Initiative. Australian and New Zealand Journal of Obstetrics and Gynaecology 2006;46:330-5.
198. Medicines and Healthcare Products Regulatory Agency. Hormone-replacement therapy: safety update - UK Public Assessment Report. http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product-specificinformationandadvice/Product-specificinformationandadvice-G-L/Hormonereplacementtherapy%28HRT%29/ (accessed 26 June 2013).
199. Villaseca P. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric 2012;15:115-24.
200. Wade C, Chao M, Kronenberg F, Cushman L, Kalmuss D. Medical pluralism among American women: results of a national survey. Journal of Women's Health 2008;17(5):829-40.
201. World Health Organisation Scientific Group. Menopause. WHO Technical Report Series 866, 1996; Vol. 7, issue 4:236-42.
202. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogenic effects of plant foods in postmenopausal women. BMJ 1990;301:905-6.
203. Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006;13(5):831-9.
204. Wiseman H, Casey K, Bowey EA, et al.Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. American Journal of Clinical Nutrition 2004;80(3):692-9.